GBI Research has found that the global parenteral nutrition (PN) market has been one of the fastest growing markets in the pharmaceutical industry and it is forecast to grow at a healthy rate in the future as well. The increase in the incidence of diseases that require PN as nutritional support along with the rise in the elderly population will be the major factors driving the market in the top seven countries (the US, Japan, the UK, Spain, Italy Germany and France).
In 2010, the global PN market was estimated to be worth $2,700m, representing a Compound Annual Growth Rate (CAGR) of 5.3% between 2002 and 2010. The market is forecast to reach $4,537m by 2017, indicating a CAGR of 7.7% between 2010 and 2017. The primary reasons for the high growth rate are the increase in the incidence of diseases that require PN as nutritional support such as cancer, acquired immunodeficiency syndrome (AIDS) and gastrointestinal (GI) disorders plus a rise in the elderly population.
The global PN market offers a broad portfolio of products. These include single dose amino acid solutions, lipid emulsions, carbohydrates, vitamins, minerals, trace elements, electrolytes, and all in one multi-chamber bags (MCBs). The latter contains all the essential nutrients in 2- or 3-chamber bags and is advantageous over other products as the MCB technology reduces the preparation time, medication errors and risk of contamination. These advantages will drive the sales of MCBs in the future and therefore contribute largely to the growth of the global PN market.
For Sample Pages, please click or add the below link to your browser
http://gbiresearch.com/RequestSamplePages.aspx?ID=Parenteral-Nutrition-Market-to-2017-Home-Care-Sector-To-Witness-Strong-Market-Growth&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report